Evaxion Biotech AS (EVAX)
3.72
-0.11
(-2.87%)
USD |
NASDAQ |
May 17, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -5.273M |
| March 31, 2022 | -8.367M |
| December 31, 2021 | -4.291M |
| September 30, 2021 | -6.627M |
| June 30, 2021 | -7.998M |
| Date | Value |
|---|---|
| March 31, 2021 | -4.377M |
| December 31, 2020 | -4.702M |
| September 30, 2020 | -2.767M |
| June 30, 2020 | -2.348M |
| March 31, 2020 | -3.014M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.367M
Minimum
Mar 2022
-2.348M
Maximum
Jun 2020
-4.976M
Average
-4.540M
Median
Free Cash Flow (Quarterly) Benchmarks
| DBV Technologies SA | -36.03M |
| Ascendis Pharma A/S | -110.55M |
| Cellectis SA | 39.44M |
| Adaptimmune Therapeutics PLC | -32.31M |
| Akari Therapeutics PLC | -- |